A community-based healthcare organization has implemented a new electronic drug prescribing system that allows prescribers...

From a quality-of-care perspective, the most meaningful measure of success for an electronic prescribing (e-prescribing) system that provides access to a complete current medication profile is the reduction in adverse events and drug abuse . The primary clinical purpose of such systems is to improve medication safety by enabling prescribers to review allergies, drug–drug interactions, duplicate therapies, contraindications, and controlled substance histories before issuing prescriptions.

Clinical informatics principles emphasize outcome-based evaluation when assessing health IT effectiveness. While satisfaction (Option A), productivity and cost reduction (Option B), and adoption rates (Option C) are important operational or implementation metrics, they do not directly measure improvements in patient safety or quality of care. True quality indicators focus on measurable clinical outcomes—such as decreased adverse drug events (ADEs), fewer medication errors, reduced inappropriate prescribing, and better monitoring of controlled substances.

By giving prescribers comprehensive medication visibility, the system helps prevent harmful interactions, overprescribing, and misuse. Therefore, the strongest quality-focused indicator of success would be a demonstrated reduction in adverse drug events and drug abuse , aligning with healthcare informatics goals of improving patient safety and clinical outcomes.